COMPASS Pathways plc

Compass Pathways PLC

Medical Care Facilities Healthcare London, United Kingdom CMPS (NMS)

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy, which is in Phase III clinical trial for the treatment of treatment-resistant depression; and is in Phase II clinical trial for treating post-traumatic stress disorder and anorexia nervosa. The company was formerly known as COMPASS Rx Limited and changed its name to COMPASS Pathways plc in August 2020. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Stock Performance (90 Days)

Data through Dec 23, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Other Medical Care Facilities Companies

View All →

Frequently Asked Questions

Has COMPASS Pathways plc had layoffs?
No layoff events have been recorded for COMPASS Pathways plc in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does COMPASS Pathways plc have?
COMPASS Pathways plc has approximately 166 employees.
What industry is COMPASS Pathways plc in?
COMPASS Pathways plc operates in the Medical Care Facilities industry, within the Healthcare sector.
Is COMPASS Pathways plc a publicly traded company?
Yes, COMPASS Pathways plc is publicly traded under the ticker symbol CMPS on the NMS. The company has a market capitalization of approximately $0.63 billion.
Where is COMPASS Pathways plc headquartered?
COMPASS Pathways plc is headquartered in London, United Kingdom.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.